S11 Ep25: FDA Approval Insights: Denileukin Diftitox in Relapsed/Refractory CTCL
OncLive® On Air - Een podcast door OncLive® On Air
Dr Foss discusses the significance of the FDA approval of denileukin diftitox for patients with relapsed/refractory CTCL.
